By Christy Santhosh Dec 2 (Reuters) - The U.S. Food and Drug Administration's drug evaluation chief, Richard Pazdur, is set ...

Dec 2 (Reuters) - The U.S. Food and Drug Administration's newly appointed head of the drug evaluation department, Richard ...

Top drug regulator Richard Pazdur filed papers to retire from the Food and Drug Administration at the end of this month, but ...

Richard Pazdur, the US Food and Drug Administration’s lead drug regulator, plans to retire from the agency only weeks after ...

Dec 2 (Reuters) - The U.S. Food and Drug Administration on Tuesday issued new draft guidance on reducing the use of lab ...

Several news outlets, including Politico, CNN and the Washington Post, reported on December 2 that Food and Drug ...

The US Food and Drug Administration’s longtime oncology chief has filed to retire from the agency just weeks after he was ...

The top drug regulator at the Food and Drug Administration, Richard Pazdur, has decided to retire from the agency just three ...

Richard Pazdur had clashed with Trump officials on the legality and pace of their initiatives. He could still withdraw his ...

FDA has determined that NRx’s Abbreviated New Drug Application (ANDA) is “substantially complete” and received for review.

Vaccine experts said the memo was irresponsible and omits key details about how officials arrived at the conclusion.

Food and Drug Administration'‌s newly appointed head of the drug evaluation ‌department, Richard Pazdur, is set to retire ...